Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
1.980
-0.050 (-2.46%)
At close: Jun 1, 2026, 4:00 PM EDT
1.970
-0.010 (-0.51%)
After-hours: Jun 1, 2026, 7:47 PM EDT
Microbot Medical Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Microbot Medical stock has a consensus rating of "Strong Buy" and an average price target of $8.50. The average 1-year stock price forecast is 329.29% higher than the current stock price, while the lowest is $5.00 (+152.53%) and the highest is $12 (+506.06%).
Price Target: $8.50 (+329.29%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 14, 2026.
Analyst Ratings
The average analyst rating for Microbot Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 3 | 3 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +506.06% | Apr 14, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $5.5 | Buy | Reiterates | $5.5 | +177.78% | Apr 13, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Initiates $5 | Buy | Initiates | $5 | +152.53% | Feb 10, 2026 |
Financial Forecast
Revenue This Year
4.45M
Revenue Next Year
9.64M
from 4.45M
Increased by 116.41%
EPS This Year
-0.32
from -0.29
EPS Next Year
-0.31
from -0.32
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 7.1M | 10.7M | ||
| Avg | 4.5M | 9.6M | ||
| Low | 2.8M | 8.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | - | 140.5% | ||
| Avg | - | 116.4% | ||
| Low | - | 91.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | -0.33 | -0.29 | ||
| Avg | -0.32 | -0.31 | ||
| Low | -0.31 | -0.32 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.